Trademark Details For DOSE FOR BLOOD PRESSURE (Serial Number 99194119)

  •  Home
  •  Print
DOSE FOR BLOOD PRESSURE
1
1
1
0
Serial Number  United States - USPTO 99194119
Registration Number -
Mark
DOSE FOR BLOOD PRESSURE
Filing Date May-20-2025
Status
Pending  
FINAL REFUSA.. (645)
FINAL REFUSAL - MAILED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameEmily Kearney The Kearney Firm, APC
Address301 Bayview Circle, Suite 104-5278 Newport Beach, CA 92660 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
May-20-2025NEW APPLICATION ENTERED   NWAPI
May-20-2025APPLICATION FILING RECEIPT MAILED   MAFRO
Sep-26-2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Oct-02-2025ASSIGNED TO EXAMINER   DOCKD
Oct-02-2025NON-FINAL ACTION WRITTEN   CNRTR
Oct-02-2025NON-FINAL ACTION E-MAILED   GNRTF
Oct-02-2025NOTIFICATION OF NON-FINAL ACTION E-MAILED   GNRNO
Nov-24-2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED   XELRI
Nov-24-2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED   XELGO
Mar-20-2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED   WOARI
Mar-20-2026WITHDRAWAL OF ATTORNEY GRANTED   WOAGI
Mar-30-2026TEAS CHANGE OF OWNER ADDRESS RECEIVED   COARI
Mar-30-2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED   CHANI
Mar-30-2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Mar-30-2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Mar-30-2026TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Apr-02-2026TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Apr-02-2026CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Apr-03-2026TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
May-06-2026FINAL REFUSAL WRITTEN   CNFRR
May-06-2026FINAL REFUSAL E-MAILED   GNFRO
May-06-2026NOTIFICATION OF FINAL REFUSAL EMAILED   GNFNO
Jul-10-2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED   XELRI
Jul-10-2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED   XELGO